Trials > Cardiovascular > VIGOUR

VIGOUR

VIGOUR (the Virtual Coordinating Center for Global Collaborative Cardiovascular Research) is an international collaboration of investigators from academic institutions in over 40 countries undertaking clinical trials on treatment for acute cardiovascular events, such as myocardial infarction and stroke.

The CTC is part of VIGOUR. It works according to the following principles for collaboration: organisations are self-sufficient, yet working collaboratively any investigator or any group can take the lead in a clinical trial each organisation maintains sufficient relevant expertise groups have compatible systems and accountability to each other for quality production common site data and site descriptors are used across the whole collaboration all groups use standard operating procedures for data management, monitoring, audit and biostatistics. The CTC has contributed to the now-completed GUSTO-I and GUSTO-II, SYMPHONY and 2nd SYMPHONY, PARAGON-B and HERO-2 trials. See international recruitment to VIGOUR trials VIGOUR collaborators Duke Clinical Research Institute (DCRI) Duke University, North Carolina, USA Cleveland Clinic Foundation (CCF) Cleveland, Ohio, USA NHMRC Clinical Trials Centre (NHMRC CTC) University of Sydney, Australia Green Lane Coordinating Centre (GLCC) Green Lane, Auckland, New Zealand Flinders Coordinating Centre (FCC) Adelaide, South Australia Flinders Clinical Trial Pharmacy (FCTP) Adelaide, South Australia Leuven Coordinating Centre (LCC) University Hospital, Gasthuisberg,Leuven, Belgium Canadian Coordinating Centre (CVC) University of Alberta, Alberta, Canada Latin American Coordinating Centre (ECLA) Rosario, Argentina